Refine by
Emergency Medicine Articles & Analysis
44 news found
Summary The SurgiCam® HD, a specialized point-of-view camera designed for clinicians, plays a pivotal role in the documentation, education, and analysis of surgical, dental, and veterinary procedures. Its high-quality image and video capturing capabilities make it an indispensable tool in these fields. This innovative camera significantly enhances surgical practices, education, and research ...
Rejuvenation/Longevity biotech is a new, emerging field of medicine. It aims to prevent and reverse diseases of aging by addressing their common root cause, the aging process itself. ...
REGEN-COV, an investigational monoclonal antibody therapy, first became available to U.S. patients in November 2020, via the FDA's Emergency Use Authorization (EUA) process for medicines that may help diagnose, treat or prevent a life-threatening disease when adequate and approved alternatives are not available. ...
Gentry Wilkerson, MD, assistant professor of emergency medicine at the University of Maryland School of Medicine, will serve as the principal investigator for the study. ...
ByCoapTech
Sewall Professor, Stanford University School of Medicine, Department of Otolaryngology – Head & Neck Surgery and Institute for Stem Cell Biology and Regenerative Medicine ISCBRM. ...
(OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions has appointed Mark Borman as Chairman of the Board as Dr. ...
Together, these factors undermined the potential of targeted medicine and phage therapy research. Hence, the beginning of the golden age of antibiotic discovery. The need for precision medicine The emergence of antibiotics created modern medicine, yielding a massive epidemiologic transition: developed countries transitioned ...
” Aclys is a leader in the emerging field of precision immune medicine. Aclys utilizes a proprietary set of patient molecular data to select differentiated targets and create precision biologics with the safety profile and response rates only achievable with precision biologics. ...
“Together, the team, project plans and resources will ensure successful commercialization of RIVANNA’s next-generation product platforms, which address a billion-dollar market opportunity in pain management, neurology, oncology and emergency ...
CytoSorb Therapy in COVID-19 (CTC) retrospective registry in the peer-reviewed journal, Frontiers in Medicine. The new publication highlights 52 critically ill COVID-19 patients from 5 major U.S. ECMO (ExtraCorporeal Membrane Oxygenation) centers who received ECMO plus CytoSorb therapy for life-threatening refractory respiratory failure under FDA EUA between April 2020 and April ...
Commercialization of the Accuro 3S and Accuro XV will address a billion-dollar market opportunity in pain management, neurology, oncology and emergency medicine. Essential space gained in the move will also increase RIVANNA’s manufacturing capacity to meet growing global demand for the Accuro product line and related medical equipment and components. ...
At CPhI Worldwide 2021, Thermo Fisher Scientific will showcase its newest capabilities across its global pharma services network which help pharmaceutical and emerging biotech companies accelerate time to market in a wide range of modalities and platforms including cell and gene therapies, drug products and biologics. ...
” The guidelines are endorsed by the American Society of Echocardiography (ASE), American College of Chest Physicians (CHEST), Society for Academic Emergency Medicine (SAEM), Society of Cardiovascular Computed Tomography (SCCT), and Society for Cardiovascular Magnetic Resonance (SCMR). ...
ByElucid
The project’s overarching objective is to achieve a market-ready, clinically proven and FDA-cleared Accuro XV product for rapid, radiation-free fracture detection and aid triage in emergency medicine; a critical medical countermeasure to ensure timely triage for reduction of morbidity and mortality in mass-casualty blast trauma incidents, for which, no ...
Lumos Diagnostics (ASX: LDX), a leader in rapid point-of-care (POC) diagnostic technologies, today announced that the Emergency Department at Box Hill Hospital in Melbourne, Australia, has initiated a 300-subject investigator-led trial using Lumos’ FebriDx® POC test to rapidly identify patients presenting with a suspected viral infection consistent with COVID-19. This ...
(OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions will take steps to relaunch its veterinary division to tackle animal health innovation. ...
Korea) and has articles published in top emergency medicine journals including; Resuscitation, Journal of the American Heart Association (JAHA) and Critical Care Medicine (CCM). ...
Sense is developing non-invasive brain scanners to meet needs identified by the company’s medical co-founders, who are specialists in emergency medicine, neurology and neurocritical care. NeuSTAT™ is currently in a pivotal trial for continuous monitoring of brain injury in an acute care setting. ...
Meticulously engineered to work within a chaotic emergency department, rural clinic or across multiple departments in a community hospital, the powerful handheld ultrasound device will be simple and intuitive to operate. ...
ByExo
Daniel Henning, a University of Washington emergency medicine physician and site principal investigator at Harborview Medical Center in Seattle, Wash. ...